These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Final results of the administration of biosynthetic growth hormone. Preliminary report].
    Author: Mendoza-Morfín F, Cárdenas-Tirado H, Montero-González P, Bravo-Ríos LE, Gutiérrez-Avila C, Torres-Tamayo M.
    Journal: Gac Med Mex; 1998; 134(1):1-7. PubMed ID: 9658693.
    Abstract:
    From March, 1987 to November, 1995, we have included 89 growth hormone-deficient children for treatment for their low height with the biosynthetic growth hormone; 23 of them have concluded treatment. Without taking into account the etiological factor of their deficiency, 6 girls and 17 boys during different lapses had modified their initial height and the scores of the standard deviation as groups, range from 113.11 +/- 14.83 cm and -5.12 +/- 1.21 to 139.11 +/- 8.96 cm. and -2.68 +/- 1.17 in the girls, and from 128.46 +/- 12.49 cm and -4.13 +/- 1.35 to 158.61 +/- 6.47 cm and -1.76 +/- 0.9 in the boys, respectively. These results between the initial height and the score of the standard deviation compared with the final height and the standard deviation score, showed a statistically significant difference of p < 0.001 both in girls and boys. Two girls and 3 boys developed hypothyroidism during the treatment, without any other side effect. We concluded that early and prolonged biosynthetic growth hormone administration in growth hormone-deficient children might produce a final adult height similar to the normal population standards.
    [Abstract] [Full Text] [Related] [New Search]